1. Home
  2. TPST vs UG Comparison

TPST vs UG Comparison

Compare TPST & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • UG
  • Stock Information
  • Founded
  • TPST 2011
  • UG 1942
  • Country
  • TPST United States
  • UG United States
  • Employees
  • TPST N/A
  • UG N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • UG Package Goods/Cosmetics
  • Sector
  • TPST Health Care
  • UG Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • UG Nasdaq
  • Market Cap
  • TPST 45.5M
  • UG 36.4M
  • IPO Year
  • TPST N/A
  • UG N/A
  • Fundamental
  • Price
  • TPST $11.02
  • UG $7.55
  • Analyst Decision
  • TPST Hold
  • UG
  • Analyst Count
  • TPST 3
  • UG 0
  • Target Price
  • TPST $30.00
  • UG N/A
  • AVG Volume (30 Days)
  • TPST 45.5K
  • UG 6.9K
  • Earning Date
  • TPST 11-11-2025
  • UG 11-07-2025
  • Dividend Yield
  • TPST N/A
  • UG 9.21%
  • EPS Growth
  • TPST N/A
  • UG N/A
  • EPS
  • TPST N/A
  • UG 0.56
  • Revenue
  • TPST N/A
  • UG $10,856,174.00
  • Revenue This Year
  • TPST N/A
  • UG N/A
  • Revenue Next Year
  • TPST N/A
  • UG N/A
  • P/E Ratio
  • TPST N/A
  • UG $13.58
  • Revenue Growth
  • TPST N/A
  • UG N/A
  • 52 Week Low
  • TPST $5.35
  • UG $7.50
  • 52 Week High
  • TPST $20.67
  • UG $15.05
  • Technical
  • Relative Strength Index (RSI)
  • TPST 58.22
  • UG 41.08
  • Support Level
  • TPST $8.87
  • UG $7.50
  • Resistance Level
  • TPST $11.07
  • UG $8.09
  • Average True Range (ATR)
  • TPST 0.47
  • UG 0.25
  • MACD
  • TPST 0.07
  • UG -0.03
  • Stochastic Oscillator
  • TPST 87.66
  • UG 3.47

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

Share on Social Networks: